Citation:Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S, et al 2012

From Cancer Guidelines Wiki

Citation


Garrido-Laguna I, Hong DS, Janku F, Nguyen LM, Falchook GS, Fu S, et al. KRASness and PIK3CAness in patients with advanced colorectal cancer: outcome after treatment with early-phase trials with targeted pathway inhibitors. PLoS One 2012;7(5):e38033 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22675430.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Optimal molecular profilingBen Lee-Batescompleted
Optimal molecular profilingDr Albert Chetcuti BTech(Biotech) Hons, PhDcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Molecular profiling of CRC|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Molecular profiling of CRC</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Optimal molecular profiling